The FDA issued a warning letter to Sanofi regarding significant manufacturing violations at its Genzyme Corporation Facility in Framingham, Mass.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA warns Sanofi over manufacturing violations
